AO
Adeoye Y Olukotun
Director

Adeoye Y Olukotun insider trades: Arrowhead Pharmaceuticals (ARWR) stock buys and sales

Director, Arrowhead Pharmaceuticals Last trade Aug 18, 2026 48 Form 4 filings
$851K
Sold, last 12 months
2 sales
$0
Bought, last 12 months
0 buys
8
Open-market trades
since 2020
7
Companies
last trade 2026

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Adeoye reports to the SEC

and 1 more company

Open-market buys and sales

8 trades reported on SEC Form 4, newest first

DateStockTypeValue
Aug 18, 2026ARWR↓ Sell$174K
Dec 19, 2025ARWR↓ Sell10b5-1$677K
Jan 23, 2025ARWR↓ Sell$20K
Dec 27, 2024ARWR↓ Sell$57K
Mar 3, 2023ARWR↓ Sell$371K
Jan 3, 2022ARWR↓ Sell10b5-1$262K
Sep 13, 2021ARWR↓ Sell$319K
Aug 13, 2020TNXP↑ Buy$5K

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

Other ARWR insiders

Open-market trades in the last 12 months

About Adeoye Y Olukotun's insider trades

Adeoye Y Olukotun is a director at Arrowhead Pharmaceuticals (ARWR). Since Aug 13, 2020, Adeoye has reported 1 open-market purchase worth $5K and 7 sales worth $1.9M on SEC Form 4. In the last 12 months: 2 sales ($851K).

2 sales (50% of the value sold) were made under a Rule 10b5-1 trading plan, which is set up months in advance and runs on a schedule, so they say little about how the insider sees the stock today.

Their filings also include grants and awards (35 filings), other transactions (3 filings), shares returned to the company (1 filing), option exercises (1 filing). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every ARWR insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.